Per Business Quant data, Emmaus Life Sciences insiders hold 12.1Mn shares in total based on their latest Form 4 filings, or 17.24% of the 70.19Mn shares outstanding.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Yutaka Niihara | Chairman And Ceo | 12,040,857 | 0 | 12,040,857 | 55.8% | 01 Dec, 2022 |
| 2 | Wei Peu Zen | Director | 4,768,817 | 0 | 4,768,817 | 22.1% | 19 Dec, 2023 |
| 3 | Seah H. Lim | Director | 4,606,626 | 0 | 4,606,626 | 21.3% | 18 Sep, 2024 |
| 4 | Willis C Lee | Co President Coo | 0 | 159,400 | 159,400 | 0.7% | 29 Feb, 2024 |
| 5 | Alfred Fu Kong Lui | Director | 10,000 | 0 | 10,000 | 0.0% | 05 Jan, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 16 Sep, 2024 | Seah H. Lim | Director | Acquired P | 20,000 | $0.04 | $800 | 4,606,626 | Direct |
| 26 Feb, 2024 | Willis C Lee | Co President Coo | Acquired P | 13,200 | $0.12 | $1.58K | 57,400 | Indirect |
| 27 Feb, 2024 | Willis C Lee | Co President Coo | Acquired P | 10,000 | $0.13 | $1.30K | 67,400 | Indirect |
| 28 Feb, 2024 | Willis C Lee | Co President Coo | Acquired P | 15,000 | $0.12 | $1.80K | 82,400 | Indirect |
| 29 Feb, 2024 | Willis C Lee | Co President Coo | Acquired P | 77,000 | $0.13 | $10.01K | 159,400 | Indirect |
| 01 Feb, 2024 | George Sekulich | Co President Cco | Acquired A | 200,000 | $0.15 | $30.00K | 200,000 | Direct |
| 01 Feb, 2024 | Seah H. Lim | Director | Acquired A | 100,000 | $0.15 | $15.00K | 100,000 | Direct |
| 01 Feb, 2024 | Charles William Stark | Cso Evp Clinical Development | Acquired A | 200,000 | $0.15 | $30.00K | 200,000 | Direct |
| 01 Feb, 2024 | Wei Peu Zen | Director | Acquired A | 100,000 | $0.15 | $15.00K | 100,000 | Direct |
| 01 Feb, 2024 | Willis C Lee | Co President Coo | Acquired A | 200,000 | $0.15 | $30.00K | 200,000 | Direct |
| 01 Feb, 2024 | Yasushi Nagasaki | Cfo | Acquired A | 200,000 | $0.15 | $30.00K | 200,000 | Direct |
| 01 Feb, 2024 | Ian Harvey Zwicker | Director | Acquired A | 100,000 | $0.15 | $15.00K | 100,000 | Direct |
| 20 Dec, 2023 | Seah H. Lim | Director | Disposed S | 32,500 | $0.05 | $1.63K | 4,586,626 | Direct |
| 15 Dec, 2023 | Wei Peu Zen | Director | Acquired J | 3,760,983 | $0.29 | $1.09Mn | 4,768,817 | Direct |
| 18 Jan, 2023 | Wei Peu Zen | Director | Disposed J | 2,000,000 | $0.50 | $1.00Mn | 0 | Direct |
| 18 Jan, 2023 | Wei Peu Zen | Director | Acquired P | 2,000,000 | $0.50 | $1.00Mn | 2,000,000 | Direct |
| 12 Jan, 2023 | Willis C Lee | Coo | Acquired A | 500,000 | $4.50 | $2.25Mn | 500,000 | Direct |
| 12 Jan, 2023 | George Sekulich | Cio Svp | Acquired A | 100,000 | $4.50 | $450.00K | 100,000 | Direct |
| 12 Jan, 2023 | Wei Peu Zen | Director | Acquired A | 100,000 | $4.50 | $450.00K | 100,000 | Direct |
| 12 Jan, 2023 | Ian Harvey Zwicker | Director | Acquired A | 100,000 | $4.50 | $450.00K | 100,000 | Direct |